WASHINGTON (Reuters) – U.S. drugs regulators gave the nod to Astellas Pharma Inc‘s pill for overactive bladder on Thursday, boosting the Japanese drugmaker’s foothold in the market for the condition.
The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.
(Reporting by Anna Yukhananov; Editing by Gerald E. McCormick)
Related posts:
Vacationing abroad? You need to detox (and here's how)
Terror attacks in Belgium coincide with attacks in France: Gladio rides again?
Judge rules Kim Dotcom mansion raid was illegal
Totalitarian NDAA Authorizes War Against Iran, says US Rep Kucinich
Video: Magician Hairy Baldini Britain’s Got Talent 2012
States with growing economies
Views: 0